Related Experiment Video
Updated: Jul 20, 2025

Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
APLNR marks a cardiac progenitor derived with human induced pluripotent stem cells
Yin-Yu Lam1, Chun-Ho Chan1, Lin Geng2
1Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, China.
Insights
Researchers identified APLNR as a novel surface marker to isolate cardiac progenitors from human induced pluripotent stem cells (hiPSCs). This method improves the consistency of generating cardiomyocytes for cardiac research and regeneration.
Area of Science:
- Stem Cell Biology
- Developmental Biology
- Cardiovascular Research
Background:
- Generating cardiomyocytes from human induced pluripotent stem cells (hiPSCs) shows variable efficiency across different cell lines and batches.
- Inconsistencies in in vitro cardiac differentiation hinder reliable applications in disease modeling and regenerative medicine.
Purpose of the Study:
- To identify reliable markers for isolating cardiac progenitor cells during hiPSC differentiation.
- To develop a robust platform for generating cardiomyocytes from diverse hiPSC lines with improved consistency.
Main Methods:
- Single-cell transcriptomics was employed on hiPSCs during cardiac differentiation to map cell lineages.
- APLNR was identified as a surface marker for cardiac progenitors, which were then isolated using immunomagnetic separation.
- Transcriptomic analysis was performed on isolated APLNR+ cardiac progenitors and compared with in vivo embryonic datasets.
Main Results:
- Single-cell transcriptomics revealed distinct cardiac and extra-cardiac lineages during hiPSC differentiation.
- APLNR+ cells were identified as a specific population of in vitro cardiac progenitors.
- Differentiation of isolated APLNR+ progenitors yielded predominantly cardiomyocytes and cardiac mesenchyme, with transient progenitor marker expression.
- APLNR expression was validated in early cardiac progenitors in human and mouse embryos.
Conclusions:
- APLNR serves as a reliable surface marker for isolating in vitro cardiac progenitors from multiple hiPSC lines without genetic modification.
- This platform offers a consistent method for generating cardiomyocytes and cardiac mesenchyme, applicable to cardiac development studies, disease modeling, and regenerative medicine.
- The findings provide a foundation for more predictable and scalable cardiomyocyte production from stem cells.
Abstract:
Cardiomyocytes can be readily derived from human induced pluripotent stem cell (hiPSC) lines, yet its efficacy varies across different batches of the same and different hiPSC lines. To unravel the inconsistencies of in vitro cardiac differentiation, we utilized single cell transcriptomics on hiPSCs undergoing cardiac differentiation and identified cardiac and extra-cardiac lineages throughout differentiation. We further identified APLNR as a surface marker for in vitro cardiac progenitors and immunomagnetically isolated them. Differentiation of isolated in vitro APLNR+ cardiac progenitors derived from multiple hiPSC lines resulted in predominantly cardiomyocytes accompanied with cardiac mesenchyme. Transcriptomic analysis of differentiating in vitro APLNR+ cardiac progenitors revealed transient expression of cardiac progenitor markers before further commitment into cardiomyocyte and cardiac mesenchyme. Analysis of in vivo human and mouse embryo single cell transcriptomic datasets have identified APLNR expression in early cardiac progenitors of multiple lineages. This platform enables generation of in vitro cardiac progenitors from multiple hiPSC lines without genetic manipulation, which has potential applications in studying cardiac development, disease modelling and cardiac regeneration.
More Related Videos
Related Concept Videos
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Stem Cell Culture

